Normal baseline cardiac ejection fraction >= % Ejection fraction of >= % Patients with angina, a cardiac ejection fraction < %, or ischemic heart disease are not eligible All included patients must have normal cardiac function as defined by an ejection fraction of >= % and no decrease in wall motion by echocardiogram All included subjects must have normal cardiac function as defined by an ejection fraction of > % by echocardiogram Cardiac ejection fraction < % (or, if unable to obtain ejection fraction, shortening fraction < %) on multiple-gated acquisition (MUGA) scan or cardiac echocardiogram (echo), symptomatic coronary artery disease, or other cardiac failure requiring therapy; patients with a history of, or current cardiac disease should be evaluated with appropriate cardiac studies and/or cardiology consult; patients with a shortening fraction of < % must be seen by cardiology for approval Cardiac function: Ejection fraction > % Ejection Fraction >= % Normal ejection fraction (echocardiogram [ECHO]) >= % (if a range is given then the upper value of the range will be used) or cardiac MRI Ejection fraction >= % Cardiac ejection fraction < % Cardiac ejection fraction < % Cardiac ejection fraction >= % as determined by screening echocardiogram Baseline cardiac ejection fraction must be >= %. Cardiac ejection fraction of >= % No uncontrolled or severe cardiac disease. Baseline ejection fraction (by nuclear imaging or echocardiography) must by ? % Cardiac ejection fraction of >= % Known cardiac ejection fraction of > or = % within the past months Ejection fraction > % History of congestive heart failure and cardiac ejection fraction =< % Cardiac ejection fraction >= % Cardiac ejection fraction at rest must be >= % Cardiac ejection fraction >= % by echocardiogram (ECHO) Ejection fraction less than % by echocardiography Participants must have normal cardiac ejection fraction (per label, as defined as institutional normal) Ejection fraction >= % Have adequate cardiac function as assessed by echocardiogram, with an ejection fraction (EF) > % Significant cardiovascular abnormalities as defined by any one of the following: congestive heart failure, clinically significant hypotension, symptomatic coronary artery disease, or a documented ejection fraction of < %; any patient with an ejection fraction (EF) of -% must receive clearance by a cardiologist to be eligible for the trial Cardiac ejection fraction greater than or equal to % by echocardiogram Cardiac ejection fraction (EF) < % Baseline ejection fraction must be >= % Baseline test of ejection fraction must be >= % Normal cardiac function must be documented within days prior to registration; result of ejection fraction must be above the normal limit of the institution Ejection fraction < %, or uncontrolled cardiac failure Ejection fraction > % Known cardiac ejection fraction < % Known cardiac ejection fraction of >= % within the past months Patients with significant lung disease, an ejection fraction less than %, or a resting heart rate less than /min will not be enrolled Cardiac ejection fraction (EF) >= % by -dimensional echocardiogram (D-ECHO) within months of study entry (or within month if received chemotherapy within the past months) Ejection fraction >= % Ejection fraction >= % on echocardiogram Cardiac ejection fraction =< % Adequate cardiac reserve with a cardiac ejection fraction within the lower limit of facility normal by MUGA, or % by echocardiogram Ejection fraction >= % Cardiac: ejection fraction > % Clinically significant heart disorders including an ejection fraction of < % Cardiac ejection fraction ? %. If between -% a cardiology consult is required Cardiac ejection fraction > % Cardiac ejection fraction less than % Known cardiac ejection fraction of >= % within the past months Cardiac ejection fraction >= % or within institutional normal limits; a nuclear medicine gated blood pool examination is preferred; a two-dimensional (-D) echocardiogram (ECHO) scan is acceptable if a calculated ejection fraction is obtained and follow-up measurement of the cardiac ejection fraction will also be performed by echocardiography; measurement of cardiac ejection fraction should be within two weeks prior to receiving treatment\r\n* NOTE: when a multi gated acquisition scan (MUGA) or echocardiogram cannot be obtained due to weekend or holiday, then patients may be enrolled provided there is no history of significant cardiovascular disease and a measurement of cardiac ejection fraction will be performed within days of study enrollment Patients must have a cardiac ejection fraction of >= %, or within institutional normal limits; a nuclear medicine gated blood pool examination is preferred; a -D ECHO scan is acceptable if a calculated ejection fraction is obtained and follow-up measurement of the cardiac ejection fraction will also be performed by echocardiography; measurement of cardiac ejection fraction should be within two weeks prior to allogeneic transplantation Cardiac ejection fraction >= % Adequate cardiac reserve (ejection fraction [EF] >= %) Cardiac ejection fraction has to be >= % Ejection fraction >= % Cardiac ejection fraction < % or, if unable to obtain ejection fraction, shortening fraction of < %) on multi-gated acquisition (MUGA) scan or cardiac echo, symptomatic coronary artery disease, other cardiac failure requiring therapy; patients with a history of, or current cardiac disease should be evaluated with appropriate cardiac studies and/or cardiology consult; patients with a shortening fraction < % may be enrolled if approved by a cardiologist Ejection fraction must be >= % Cardiac ejection fraction >= % Pre-existing known cardiovascular abnormalities as defined by any one of the following: \t\r\n* Congestive heart failure \r\n* Clinically significant hypotension \r\n* Cardiac ischemia, or symptoms of coronary artery disease\r\n* Presence of cardiac arrhythmias on electrocardiogram (EKG) requiring drug therapy\r\n* Ejection fraction < % (echocardiogram or MUGA), although any patient with an ejection fraction between -% must receive clearance by a cardiologist to be eligible for Step II of the trial Pre-existing known cardiovascular abnormalities as defined by any one of the following: \t\r\n* Congestive heart failure \r\n* Clinically significant hypotension \r\n* Cardiac ischemia, or symptoms of coronary artery disease\r\n* Presence of cardiac arrhythmias on EKG requiring drug therapy\r\n* Ejection fraction < %, although any patient with an ejection fraction between -% must receive clearance by a cardiologist to be eligible for Step II of this trial Cardiac ejection fraction ? % and no clinically significant ECG findings Cardiac ejection fraction >= % Normal cardiac ejection fraction of > % Ejection fraction > % on echocardiogram Cardiac history of CHF requiring treatment or Ejection Fraction less than or equal to % or chronic stable angina; Cardiac ejection fraction < % Ejection fraction >= % by echocardiogram Ejection fraction >= % Cardiac ejection fraction >= % Cardiac ejection fraction > % Ejection fraction > % Cardiac ejection fraction >= % Cardiac ejection fraction ? % by echocardiography or MUGA Ejection fraction >= % (within weeks prior to study enrollment) Ejection fraction (EF) < % or uncontrolled cardiac failure Ejection fraction (EF) >= % Cardiac ejection fraction > % Cardiac ejection fraction < %; ejection fraction is required if age > years or there is a history of prior transplant, anthracycline exposure or history of cardiac disease; and poorly controlled hypertension despite multiple antihypertensives Cardiac ejection fraction (EF) < % on multi-gated acquisition (MUGA) scan or cardiac echocardiogram (echo) (or if unable to obtain ejection fraction, shortening fraction of < %); patients with active or a history of cardiac disease should be evaluated with appropriate cardiac studies and/or consult; ejection fraction is required if age > years or there is a history of anthracyclines or history of cardiac disease; patients with a shortening fraction < % may be enrolled if approved by a cardiologist Known ejection fraction < %. Ejection fraction equal or above % Cardiac ejection fraction within normal limits as measured by echocardiogram Patients with poor cardiac function defined as an ejection fraction (EF) < % are excluded Ejection fraction >= % by echocardiogram Ejection fraction < % No history of serious cardiac arrhythmia or ejection fraction (EF) < % Known heart failure (ejection fraction [EF] < %) Cardiac ejection fraction (EF) >= % by -dimensional echocardiogram (D-Echo) Ejection fraction (EF) >= % Cardiac ejection fraction >= % without evidence of congestive heart failure (CHF) Patients with poor cardiac function as defined by an ejection fraction < % are excluded (only for patients enrolled on second phase of protocol for leukapheresis) Abnormal baseline cardiac function defined as an ejection fraction of less than % Cardiac ejection fraction < (using motion [M]-Mode if assessment is done by echocardiogram [ECHO]) Cardiac ejection fraction >= % Cardiac ejection fraction > % Adequate cardiac function defined as an ejection fraction of at least % Ejection fraction at rest >= % Cardiac function: ejection fraction > % Cardiac function: Ejection fraction at rest ? % Patients must have normal cardiac ejection fraction Participants must have normal cardiac ejection fraction Cardiac ejection fraction >% (by echocardiogram or MUGA) within days of enrollment The patients estimated cardiac ejection fraction is < % by echocardiogram or MUGA Patient has a cardiac ejection fraction <%